{"id":"https://openalex.org/W2291985358","doi":null,"title":"\u0418\u0437\u0443\u0447\u0435\u043d\u0438\u0435 \u0432\u043b\u0438\u044f\u043d\u0438\u044f \u044d\u0442\u0438\u043b\u043c\u0435\u0442\u0438\u043b\u0433\u0438\u0434\u0440\u043e\u043a\u0441\u0438\u043f\u0438\u0440\u0438\u0434\u0438\u043d\u0430 \u0433\u0435\u043c\u0438\u0441\u0443\u043a\u0446\u0438\u043d\u0430\u0442\u0430 \u043d\u0430 \u0431\u0438\u043e\u0445\u0438\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0441\u043e\u0441\u0442\u0430\u0432 \u043a\u0440\u043e\u0432\u0438 \u043a\u0440\u043e\u043b\u0438\u043a\u043e\u0432 \u043f\u0440\u0438 \u0432\u0432\u0435\u0434\u0435\u043d\u0438\u0438 \u0434\u043e\u043a\u0441\u043e\u0440\u0443\u0431\u0438\u0446\u0438\u043d\u0430","display_name":"\u0418\u0437\u0443\u0447\u0435\u043d\u0438\u0435 \u0432\u043b\u0438\u044f\u043d\u0438\u044f \u044d\u0442\u0438\u043b\u043c\u0435\u0442\u0438\u043b\u0433\u0438\u0434\u0440\u043e\u043a\u0441\u0438\u043f\u0438\u0440\u0438\u0434\u0438\u043d\u0430 \u0433\u0435\u043c\u0438\u0441\u0443\u043a\u0446\u0438\u043d\u0430\u0442\u0430 \u043d\u0430 \u0431\u0438\u043e\u0445\u0438\u043c\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0441\u043e\u0441\u0442\u0430\u0432 \u043a\u0440\u043e\u0432\u0438 \u043a\u0440\u043e\u043b\u0438\u043a\u043e\u0432 \u043f\u0440\u0438 \u0432\u0432\u0435\u0434\u0435\u043d\u0438\u0438 \u0434\u043e\u043a\u0441\u043e\u0440\u0443\u0431\u0438\u0446\u0438\u043d\u0430","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2291985358","mag":"2291985358"},"language":"ru","primary_location":{"id":"mag:2291985358","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/izuchenie-vliyaniya-etilmetilgidroksipiridina-gemisuktsinata-na-biohimicheskiy-sostav-krovi-krolikov-pri-vvedenii-doksorubitsina","pdf_url":null,"source":{"id":"https://openalex.org/S4306538606","display_name":"\u0412\u0435\u0441\u0442\u043d\u0438\u043a \u043d\u043e\u0432\u044b\u0445 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0445 \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0439","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u0412\u0435\u0441\u0442\u043d\u0438\u043a \u043d\u043e\u0432\u044b\u0445 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0445 \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0439","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2291985358"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022303661","display_name":"\u041d. \u0418. \u041c\u0438\u043a\u0443\u043b\u044f\u043a","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041d. \u0418. \u041c\u0438\u043a\u0443\u043b\u044f\u043a","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102859802","display_name":"\u0410. \u041d. \u041c\u0438\u0442\u0440\u043e\u0448\u0438\u043d","orcid":"https://orcid.org/0000-0002-7694-1865","observed_orcids":["https://orcid.org/0000-0002-7694-1865"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0410. \u041d. \u041c\u0438\u0442\u0440\u043e\u0448\u0438\u043d","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7694-1865","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037506367","display_name":"\u0410. \u0418. \u041c\u0438\u043a\u0443\u043b\u044f\u043a","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0410. \u0418. \u041c\u0438\u043a\u0443\u043b\u044f\u043a","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.5551999807357788,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.5551999807357788,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.37130001187324524,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.029400000348687172,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/doxorubicin-induced-cardiotoxicity","display_name":"doxorubicin cardiotoxicity","score":0.6579999923706055},{"id":"https://openalex.org/keywords/cytolytic-syndrome","display_name":"cytolytic syndrome","score":0.6589999794960022},{"id":"https://openalex.org/keywords/cholestasis","display_name":"cholestasis","score":0.9739999771118164},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.8930000066757202},{"id":"https://openalex.org/keywords/antioxidant-activity","display_name":"antioxidant activity","score":0.7799999713897705},{"id":"https://openalex.org/keywords/rabbits","display_name":"rabbits","score":0.6520000100135803},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.756182074546814},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.542271077632904},{"id":"https://openalex.org/C2778593092","wikidata":"https://www.wikidata.org/wiki/Q1075923","display_name":"Cholestasis","level":2,"score":0.45000413060188293},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44478166103363037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36902570724487305}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2291985358","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/izuchenie-vliyaniya-etilmetilgidroksipiridina-gemisuktsinata-na-biohimicheskiy-sostav-krovi-krolikov-pri-vvedenii-doksorubitsina","pdf_url":null,"source":{"id":"https://openalex.org/S4306538606","display_name":"\u0412\u0435\u0441\u0442\u043d\u0438\u043a \u043d\u043e\u0432\u044b\u0445 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0445 \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0439","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u0412\u0435\u0441\u0442\u043d\u0438\u043a \u043d\u043e\u0432\u044b\u0445 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0445 \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0439","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1108497030","https://openalex.org/W7043897900","https://openalex.org/W7160939538","https://openalex.org/W2583513361","https://openalex.org/W1861701716","https://openalex.org/W2605429440","https://openalex.org/W1864453811","https://openalex.org/W2414015497","https://openalex.org/W3041702221","https://openalex.org/W7072495067"],"abstract_inverted_index":{"The":[0,24],"results":[1],"of":[2,21,26],"study":[3],"demonstrate":[4],"possibilities":[5],"ethylmethylhydroxypiridine":[6],"hemisuccinate":[7],"to":[8,33],"eliminate":[9],"induced":[10],"doxorubicin":[11,37],"cytolitic":[12],"syndrome,":[13],"cholestasis,":[14],"hepatic":[15],"cell":[16],"insufficiency,":[17],"form":[18],"tense":[19],"condition":[20],"antioxidation":[22],"effects.":[23],"use":[25],"this":[27],"preparations":[28],"in":[29],"oncological":[30],"therapy":[31],"allows":[32],"conduct":[34],"chemotherapy":[35],"including":[36]},"counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}